Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Emerging Technology Partners

Founders Wei-Wu He

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 19
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 15
Rounds per year 0.79
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.21
Exits 8
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Genetics
  • Medical
  • Health Diagnostics
Summary

Emerging Technology Partners is the famous VC, which was founded in 2000. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the San Francisco.

The fund was created by Wei-Wu He. Besides them, we counted 1 critical employee of this fund in our database.

The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 10 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Emerging Technology Partners performs on 31 percentage points more the average number of lead investments. The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2015.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Emerging Technology Partners, startups are often financed by Solstice Capital, Village Ventures, Valley Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, MPM Capital, Alta Partners. In the next rounds fund is usually obtained by TPG, InterWest Partners, Alta Partners.

Among the most successful fund investment fields, there are Biotechnology, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CASI Pharmaceuticals, Polaris Biology, Intradigm Corporation. The fund has exact preference in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Emerging Technology Partners:
Typical Co-investors
Emerging Technology Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Emerging Technology Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Baker Brothers Advisors LLC New York, New York, United States
Crescent Enterprises Venture Capital Sharjah, Sharjah Emirate, United Arab Emirates
Forbes Family Trust New York, New York, United States
Global Millennial Capital Dubai, United Arab Emirates
Granger Management LLC -
Janchor Partners China, Hong Kong, Hong Kong Island
Liangcang Accelerator China, Hangzhou, Zhejiang
Panthera Capital Ventures Dubai, United Arab Emirates
Rongyin Capital Beijing, China, Haidian
Shanghai Houting Management Consulting China, Shanghai
Shibuya Kogyo Ishikawa Prefecture, Japan, Kanazawa
Strategic Equities -
The Eleos Foundation California, Santa Barbara, United States
TIM Italy, Lazio, Roma
Topfonds Gelderland -
V8 Capital Partners Ebène, Mauritius, Plaines Wilhems
Venvest Capital California, Santa Monica, United States
Vilitas GmbH & Co. KG Aachen, Germany, Nordrhein-Westfalen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Human Longevity

Biotechnology
Genetics
Health Care
Health Diagnostics
$39M21 Aug 2024 San Diego, California, United States

Heranova Lifesciences

Biotechnology
Health Care
Medical
$3M28 Dec 2023 Huangpu, Shanghai, China

Polaris Biology

Biopharma
Biotechnology
Health Care
Medical
$10M24 Jun 2020 Shanghai, China

Human Longevity

Biotechnology
Genetics
Health Care
Health Diagnostics
$30M07 Nov 2019 San Diego, California, United States

Polaris Biology

Biopharma
Biotechnology
Health Care
Medical
$8M21 Jan 2019 Shanghai, China

DoctorsForMe Inc

Health Care
Medical
$1M23 Mar 2018 South San Francisco, California, United States

TCR Cure

Health Care
Medical
Pharmaceutical
01 Jun 2017 Nansha District, Guangdong Province, China

Intradigm Corporation

Biotechnology
Health Care
Therapeutics
$16M21 Nov 2006 Palo Alto, California, United States

HTG Molecular Diagnostics

Biotechnology
Genetics
Health Diagnostics
Life Science
Medical
$3M19 Oct 2005 Tucson, Arizona, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Emerging Technology Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 19
Average round size 15M
Rounds per year 0.79
Peak activity year 2019
Lead investments 4
Follow on index 0.21
Exits 8
Group Appearance index 0.74

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Human Longevity

Biotechnology
Genetics
Health Care
Health Diagnostics
$39M21 Aug 2024 San Diego, California, United States

Heranova Lifesciences

Biotechnology
Health Care
Medical
$3M28 Dec 2023 Huangpu, Shanghai, China

Polaris Biology

Biopharma
Biotechnology
Health Care
Medical
$10M24 Jun 2020 Shanghai, China

Human Longevity

Biotechnology
Genetics
Health Care
Health Diagnostics
$30M07 Nov 2019 San Diego, California, United States

Polaris Biology

Biopharma
Biotechnology
Health Care
Medical
$8M21 Jan 2019 Shanghai, China

DoctorsForMe Inc

Health Care
Medical
$1M23 Mar 2018 South San Francisco, California, United States

TCR Cure

Health Care
Medical
Pharmaceutical
01 Jun 2017 Nansha District, Guangdong Province, China

Intradigm Corporation

Biotechnology
Health Care
Therapeutics
$16M21 Nov 2006 Palo Alto, California, United States

HTG Molecular Diagnostics

Biotechnology
Genetics
Health Diagnostics
Life Science
Medical
$3M19 Oct 2005 Tucson, Arizona, United States
Crunchbase icon

Content report

The following text will be sent to our editors: